Immunoproteasome induction is suppressed in hepatitis C virus-infected cells in a protein kinase R-dependent manner-Reference-Cited by-同舟云学术

Immunoproteasome induction is suppressed in hepatitis C virus-infected cells in a protein kinase R-dependent manner

Published:2016-11 Issue:11 Volume:48 Page:e270-e270
ISSN:2092-6413
Container-title:Experimental & Molecular Medicine
language:en
Short-container-title:Exp Mol Med

Author:

Oh In Soo,Textoris-Taube Kathrin,Sung Pil Soo,Kang Wonseok,Gorny Xenia,Kähne Thilo,Hong Seon-Hui,Choi Young Joon,Cammann Clemens,Naumann Michael,Kim Jong Hoon,Park Su-Hyung,Yoo Ook Joon,Kloetzel Peter M,Seifert Ulrike,Shin Eui-Cheol

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://www.nature.com/articles/emm201698.pdf

Reference41 articles.

1. Klein J, Sato A . The HLA system. First of two parts. N Engl J Med 2000; 343: 702–709.

2. Rammensee HG, Friede T, Stevanoviic S . MHC ligands and peptide motifs: first listing. Immunogenetics 1995; 41: 178–228.

3. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994; 78: 761–771.

4. Glickman MH, Ciechanover A . The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002; 82: 373–428.

5. Kloetzel PM . Antigen processing by the proteasome. Nat Rev Mol Cell Biol 2001; 2: 179–187.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits;PLOS Biology;2024-03-06

2. Ubiquitin–proteasome system and the role of its inhibitors in cancer therapy;Open Biology;2021-04

3. ER‐aminopeptidase 1 determines the processing and presentation of an immunotherapy‐relevant melanoma epitope;European Journal of Immunology;2019-11-27

4. Immunoproteasome-selective inhibitors: An overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases;European Journal of Medicinal Chemistry;2019-11